Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company developing life-altering therapeutics.
Sector
Subsector
Location
total rounds
total raised
Auspex Pharmaceuticals
Auspex Pharmaceuticals develops therapeutics for depressive disorders and orphan diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Idera Pharmaceuticals
Idera Pharmaceuticals develops DNA- and RNA-based drugs for various diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Addex Therapeutics
Addex Therapeutics develops and sells small molecule drugs for neurological disorders.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds8
Number of Funding Rounds
Money Raised
Their latest funding was raised on 05.12.2022. Their latest investor HealthCor Partners. Their latest round Post-IPO Equity
Avidity Partners
Avidity Partners is an investment management firm that offers financial services.
Sector
Subsector
Keywords
count Of Investments
count Of Exists
Co-Investors
Investors14
Number of lead investors
Number of investors
HealthCor Partners
HealthCor Partners is a registered investment advisor focused on private equity investments in the healthcare and life sciences industry.
Sector
Subsector
Location
count Of Investments
count Of Exists
Heights Capital Management
Heights Capital Management, Inc. is a private equity firm specializing in private investments in public equity in emerging growth companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Armistice Capital
Armistice Capital is a global hedge fund focused on healthcare and consumer sectors.
Sector
Subsector
Keywords
count Of Investments
People
Founders3
Michael Christiano
Michael Christiano is the Chief Business Officer at the Broad Institute of MIT and Harvard. Michael Christiano attended Cornell University.
current job
organization founded
Michael Christiano
Ronald A. DePinho
Ronald DePinho is the Co-Founder & Chairman of the Scientific Advisory Board at Nirogy Therapeutics.
current job
organization founded
Ronald A. DePinho
Sharon Shacham
Dr. Shacham founded Karyopharm in 2008 and has served as our Chief Scientific Officer and President of Research and Development since December 2012, as our Chief Scientific Officer and Head of Research and Development from October 2010 to December 2012 and as our President and Chief Executive Officer from October 2010 to January 2011. Dr. Shacham has led our scientific progress since inception. Prior to joining Karyopharm, from 2000 to April 2009, she was Senior Vice President of Drug Development at Epix Pharmaceuticals, Inc., which underwent liquidation proceedings in 2009, and Director, Algorithm and Software Development at Predix Pharmaceuticals Inc. which merged into Epix Pharmaceuticals in 2006, where she led the company’s efforts in GPCR modeling, computational chemistry, lead optimization and development of clinical trials. Dr. Shacham received her B.Sc. in Chemistry, Ph.D. and M.B.A. from Tel Aviv University.
current job
organization founded
Sharon Shacham
Employee Profiles94
Ashley Mccarron
Director and counsel contracts management
Aileen Waters
Associate director, investigational product quality, karyopharm
Tanya Lewis
Executive vice president, chief regulatory and quality officer
Rachel Hansard
Vice president of marketing and market insights
Paula Larson
Associate director, accounting and reporting
Activity
Recent News24
The graph reveals the ratio (%) of positive news articles in a chosen time range